Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jul;94(7):1147-51.
doi: 10.2105/ajph.94.7.1147.

Medically eligible women who do not use HAART: the importance of abuse, drug use, and race

Mardge H Cohen  1 , Judith A Cook, Dennis Grey, Mary Young, Lawrence H Hanau, Phyllis Tien, Alexandra M Levine, Tracey E Wilson
Affiliations

Medically eligible women who do not use HAART: the importance of abuse, drug use, and race

Mardge H Cohen et al. Am J Public Health. 2004 Jul.

Abstract

Objectives: We investigated the prevalence and characteristics of HIV-positive women who do not report highly active antiretroviral therapy (HAART) use.

Methods: We analyzed HAART use among 1165 HIV-positive participants in the Women's Interagency HIV Study.

Results: Between October 1, 2000, and March 31, 2001, 254 women with clinical indications for HAART reported not using it, 635 reported HAART use, and 276 had no clinical indications. In multivariate analysis, using crack/cocaine/heroin and a history of abuse decreased the likelihood of using HAART, whereas being White increased it.

Conclusions: One of 4 women for whom HAART was indicated reported not using HAART. Childhood sexual abuse prevention, more intensive abuse treatment, and continuing drug treatment may enhance HIV disease treatment of women.

PubMed Disclaimer

References

    1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 2001;13 (2):1–44.
    1. Whitman S, Murphy J, Cohen M, Sherer R. Marked declines in human immunodeficiency virus—related mortality in Chicago in women, African Americans, Hispanics young adults, and injection drug users, from 1995–1997. Arch Intern Med. 2000;160:365–369. - PubMed
    1. Moore AL, Sabin CA, Johnson MA, Phillips AN. Gender and clinical outcomes after starting highly active antiretroviral treatment: a cohort study. J Acquir Immune Defic Syndr. 2002;29:197–202. - PubMed
    1. Gange SJ, Barron Y, Greenblatt RM, et al. Effectiveness of highly active antiretroviral therapy among HIV-1 infected women. J Epidemiol Community Health. 2002;56:153–159. - PMC - PubMed
    1. Cohen MH, French AL, Benning L, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med. 2002;113:91–98. - PMC - PubMed

Publication types

MeSH terms